AnaptysBio

-$0.15 (-0.64%) As of 5:43 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.

CEO
Hamza Suria
Employees
94
Headquarters
San Diego, California
Founded
2005

ANAB Key Statistics

Market Cap
637.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
233.74K
High Today
$23.77
Low Today
$23.01
Open Price
$23.29
Volume
22.70K
52 Week High
$35.85
52 Week Low
$13.92

ANAB Earnings

-$1.20
-$0.34
$0.53
$1.39
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure